Its overexpression can inhibit the prolifera tion, migration, and invasion of CRC cells, possibly by targeting AP1S1, suggesting the dual potential of miR-7847-3p as a prognostic biomarker and therapeutic target. This evidence concerns the gene AP1S1 and colorectal carcinoma.